Trading update

RNS Number : 8045N

Tristel PLC

21 May 2015

 



21 May 2015

Tristel plc

("Tristel" or the "Company")

Trading update

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products provides a trading update for the year ending 30 June 2015.

Tristel addresses three distinct markets: Human Healthcare, Animal Healthcare and Contamination Control, with three distinctively branded product ranges: Tristel, Anistel and Crystel.

The Group has performed ahead of budget in both sales and profit terms over the ten months to 30 April 2015.  The strong profit performance can be pinpointed to the Group's direct operations in the UK, Germany and Australasia.  Amongst our direct operations, the only disappointing area has been Russia, where the Board continues to review its future prospects.

The Company has raised its internal expectations for the current financial year, and pre-tax profit (before share-based payments) is now expected to be not less than £2.5m (2014: £1.8m) 

Paul Swinney, Chief Executive, comments "The sales momentum that has built within the business over the course of the past two and a half years is being maintained. Our cost base is well controlled and the organisation is dealing well with the execution of our growth strategy.  All of this translates to a record profit to be reported for the year".

For further information please contact:       

Tristel plc	www.tristel.com
Paul Swinney, Chief Executive Officer	Tel: [phone]
Liz Dixon, Finance Director
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]
finnCap	Tel: [phone]
Geoff Nash (Corporate Finance)
Charlotte Stranner (Corporate Finance)
Stephen Norcross (Corporate Broking)

 

END

 

 

MSCLBLFLEEFZBBK